Medtech Startup Sunfox Technologies Raises $7 Mn in Series A Round to Expand its Footprint

The fresh capital is expected to support its next phase of growth, including expanding its presence across India, developing global go-to-market capabilities, scaling the organisation, and supporting ongoing R&D work.

Medtech startup Sunfox Technologies has raised $7 million in a Series A funding round led by investors Ashish Kacholia, Lashit Sanghvi, Alchemy Capital, and 3one4 Capital.

The fresh capital is expected to support its next phase of growth, including expanding its presence across India, developing global go-to-market capabilities, scaling the organisation, and supporting ongoing research and development work.

The Dehradun-based startup had previously raised INR 15 crore in a pre-Series A funding round in August 2024.

The funding round was led by Venture Catalysts, with participation from Finvolve through the IA Growth Opportunities Fund I and Brew Opportunities Fund, Universal Group, RP Singhvi Group, and others in August 2024.

It also secured investments from all five Sharks in the first season of Shark Tank India.

Founded in 2016 by Rajat Jain, Arpit Jain, Saurabh Badola, Nitin Chandola, and Sabit Rawat, Dehradun-based Sunfox Technologies develops portable and AI-enabled healthcare solutions, with a focus on diagnostic access, particularly in cardiac care.

Its flagship Spandan series is designed as a portable, medical-grade ECG platform designed for use across hospitals, clinics, telemedicine networks, and home-based patient monitoring.

The platform enables ECGs to be recorded closer to patients and can flag cardiac patterns that may require further medical attention.

It has developed multiple Spandan ECG solutions for personal, clinical, and institutional use, with applications across home-based ECG recording, clinics, hospitals, public-health programmes, and remote-care networks.

According to the startup, it has expanded its presence to more than 15 countries, while its products have reached healthcare providers across more than 1,800 PIN codes in India.

Its technology can also be deployed through a hub-and-spoke model in public-health systems.

Sunfox also reported that around 60,000 Spandan devices have been deployed across India, covering more than 20,000 villages across states and union territories.

Further, its Spandan One platform has been used to screen approximately 5 million patients annually.

By leveraging the Series A capital, the startup plans to scale its India-built cardiac diagnostics platform domestically while developing regulatory, distribution, and commercial capabilities across priority international markets.

The startup is also targeting international markets including the United States, Europe and Africa, alongside continued expansion of its domestic footprint.

Commenting on the latest funding, Rajat Jain, Founder and CEO of Sunfox Technologies, said, “This round gives us the resources to take what we have built in Dehradun to a much larger stage. We will invest deeply in R&D while expanding across India and building the capabilities required to take Sunfox and Spandan to global markets.”

Stay tuned for more such updates on Digital Health News